ArticleFrontiers in pharmacology2020

Long-Term Follow-Up and Optimization of Interleukin-1 Inhibitors in the Management of Monogenic Autoinflammatory Diseases: Real-Life Data from the JIR Cohort.

Véronique Hentgen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.